Aarogya Pay to Make Healthcare Accessible with EMIs, Zero Interest Loans


Navia Life Care, a smart healthcare provider, recently launched “Aarogya Pay” – a digital process to make instant loans (Buy Now Pay Later) available to patients. With this launch, the company aims to make medical treatment accessible to patients, by enabling instant zero-rate and 3/6 EMI loans, it said in a press release.

Given the skyrocketing medical costs, health insurance policies do not meet the requirements. In many cases, people have to run from pillar to post and need immediate funds to start treatment, the statement said.

How it works?

Aarogya Pay is a fully digital process where a QR code is installed at the doctor’s clinic.

After scanning the code, Aarogya Pay helps patients to benefit and get approved medical loan instantly.

Aarogya Pay provides a pre-approved credit limit of up to Rs 60,000 per patient. Patients can avail the loan for medical procedures, treatments, consultations, drug purchases and lab tests, he said.

BNPL, zero cost EMI options

Gaurav Gupta, co-founder of Navia Life Care, said, “Insurance penetration in the country is low resulting in high out-of-pocket expenses for patients. This in turn leads to poor quality of care as patients postpone their treatments to later dates. Aarogya Pay aims to change that by offering patients an instant zero-cost EMI/Buy Now option.

Navia Life Care has partnered with RBI registered financial institutions for instant credit procedures and availability. By scanning the QR code, patients are required to e-KYC and instantly know their loan eligibility. After verification, the loan is approved and disbursed instantly.

“Navia works with over 22,000 physicians and helps physicians increase patient volumes and revenue with smart EMR and digital prescribing. For Arogya Pay, Navia has an ambitious goal to achieve. We are targeting transactions worth Rs. 100 crores on the Aarogya Pay platform over the next 6 months. said Nupur Khandelwal, co-founder of Navia Life Care.

Posted: Friday, May 20, 2022, 1:43 PM IST


About Author

Comments are closed.